PTGS2 and central nervous system cancer: Examination of glioma expression data from The Cancer Genome Atlas (TCGA) demonstrated that Cox-2 expression increases with increasing tumor grade (Figure 1B) and is enriched in the mesenchymal subgroup (Figure 1C).